Pirfenidone For Idiopathic Pulmonary Fibrosis: Results Of A Nationwide Danish Experience

被引：0
|
作者：
Salih, G. N. [1 ]
Shaker, S. B. [1 ]
Madsen, H. D. [2 ]
Bendstrup, E. [3 ]
机构：
[1] Gentofte Univ Hosp, Hellerup, Denmark
[2] Odense Univ Hosp, DK-5000 Odense, Denmark
[3] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4397
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pirfenidone for idiopathic pulmonary fibrosis: could it be a panacea?
    Antoniou, Katerina M.
    Bouros, Demosthenes
    PNEUMON, 2011, 24 (04) : 352 - 354
  • [42] The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
    Cottin, Vincent
    RESPIRATORY RESEARCH, 2013, 14
  • [43] EARLY CLINICAL EXPERIENCE WITH PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE UK: INTERIM RESULTS FROM A UK COHORT
    Parfrey, H.
    Leonard, C.
    Gibbons, M. A.
    Harris, E.
    Frank, R.
    Sharp, C.
    Dew, R. M.
    Maher, T. M.
    THORAX, 2012, 67 : A48 - A49
  • [44] EXTENDED CLINICAL EXPERIENCE WITH PIRFENIDONE DURING A NAMED PATIENT PROGRAMME FOR IDIOPATHIC PULMONARY FIBROSIS (IPF): INTERIM RESULTS
    Partfrey, H.
    Chaudhuri, N.
    Gibbons, M. A.
    Anning, L.
    Balkin, M.
    Cooper, S.
    Dew, R.
    Maher, T. M.
    THORAX, 2014, 69 : A196 - A196
  • [45] Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial
    Vancheri, Carlo
    Kreuter, Michael
    Richeldi, Luca
    Ryerson, Christopher J.
    Valeyre, Dominique
    Grutters, Jan C.
    Wiebe, Sabrina
    Stansen, Wibke
    Quaresma, Manuel
    Stowasser, Susanne
    Wuyts, Wim A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (03) : 356 - 363
  • [46] Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
    Vietri, Lucia
    Cameli, Paolo
    Perruzza, Marco
    Cekorja, Behar
    Bergantini, Laura
    D'Alessandro, Miriana
    Refini, Rosa Metella
    Pieroni, Maria
    Fossi, Antonella
    Bennett, David
    Spalletti, Marco
    Mazzei, Maria Antonietta
    Sestini, Piersante
    Rottoli, Paola
    Bargagli, Elena
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [47] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [48] Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
    Chang, Cheng-Yu
    Wei, Yu-Feng
    Chen, Chung-Yu
    Lai, Yi-Chun
    Hu, Po-Wei
    Hung, Jui-Chi
    Chu, Chi-Hsiang
    Chuang, Hsin-Tzu
    Chang, Shih-Chieh
    FRONTIERS IN MEDICINE, 2023, 10
  • [49] SINGLE CENTRE EXPERIENCE OF SWITCHING PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS FROM PIRFENIDONE TO NINTEDANIB
    Rathnapala, A.
    Fries, A.
    Ruggiero, C.
    Ho, L. P.
    Hoyles, R. K.
    THORAX, 2016, 71 : A60 - A60
  • [50] PREDICTIVE FACTORS FOR THE EFFECT OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Ichimura, Yasunori
    Tsushima, Kenji
    Matsumura, Takuma
    Yamagishi, Kazutaka
    Abe, Mitsuhiro
    Ikari, Jun
    Terada, Jiro
    Tastumi, Koichiro
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017, 34 (04) : 290 - 299
12345